DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM).
2010 Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Beretta, Gd; Caffo, O; Caroti, C; Crinò, L; DE LAURENTIIS, Michelino; Dinota, A; Di Vito, F; Gebbia, V; Giustini, L; Graiff, C; Guida, M; Lelli, G; Lombardo, M; Muggiano, A; Puglisi, F; Romito, S; Salvagno, L; Tagliaferri, P; Terzoli, E; Venturini, M; AIOM Working Group Interaction with Regional, Sections
[Exemestane in the treatment of breast carcinoma: recent findings]
2008 DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano
Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer.
2008 Cancello, G.; Montagna, E.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Di Lorenzo, G.; Plaitano, M.; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
1993 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
1995 Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
2008 DE LAURENTIIS, Michelino; Cancello, G.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Montagna, E.; Lauria, Rossella; Forestieri, Valeria; Esposito, A.; Silvestro, L.; Pennacchio, R.; Criscitiello, C.; Montanino, A.; Limite, Gennaro; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
2000 DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
Prognostic significance of multifocality in primary breast cancer.
1994 Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
IS THERE A STANDARD CHEMOTHERAPEUTIC REGIMEN FOR HORMONE-REFRACTORY PROSTATE CANCER? PRESENT AND FUTURE APPROACHES IN THE MANAGEMENT OF THE DISEASE.
2003 DI LORENZO, G; Autorino, R; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, R; Giordano, A; DE SIO, M; Darmiento, M; Bianco, Ar; DE PLACIDO, Sabino
Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer.
2012 Giordano, A; Gao, H; Anfossi, S; Cohen, E; Mego, M; Lee, Bn; Tin, S; DE LAURENTIIS, Michelino; Parker, Ca; Alvarez, Rh; Valero, V; Ueno, Nt; DE PLACIDO, Sabino; Mani, Sa; Esteva, Fj; Cristofanilli, M; Reuben, Jm
NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA
2000 Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A.
2000 Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab.
2009 E., Montagna; G., Cancello; D., D'Agostino; Lauria, Rossella; Forestieri, Valeria; A., Esposito; L., Silvestro; Accurso, Antonello; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
2002 Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
A predictive index of axillary nodal involvement in operable breast cancer.
1996 DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
1994 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
1999 DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM). | 1.1 Articolo in rivista | 2010 | Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Beretta, Gd; Caffo, O; Caroti, C; Crinò, L; DE LAURENTIIS, Michelino; Dinota, A; Di Vito, F; Gebbia, V; Giustini, L; Graiff, C; Guida, M; Lelli, G; Lombardo, M; Muggiano, A; Puglisi, F; Romito, S; Salvagno, L; Tagliaferri, P; Terzoli, E; Venturini, M; AIOM Working Group Interaction with Regional, Sections | |
| [Exemestane in the treatment of breast carcinoma: recent findings] | 1.1 Articolo in rivista | 2008 | DE LAURENTIIS, Michelino; Carmen, Criscitiello; Agnese, Montanino; Claudette, Falato; Monica, Plaitano | |
| Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer. | 1.1 Articolo in rivista | 2008 | Cancello, G.; Montagna, E.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Di Lorenzo, G.; Plaitano, M.; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino | |
| Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. | 1.1 Articolo in rivista | 1993 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
| The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials | 1.1 Articolo in rivista | 2008 | DE LAURENTIIS, Michelino; Cancello, G.; D'Agostino, D.; Giuliano, Mario; Giordano, A.; Montagna, E.; Lauria, Rossella; Forestieri, Valeria; Esposito, A.; Silvestro, L.; Pennacchio, R.; Criscitiello, C.; Montanino, A.; Limite, Gennaro; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. | 1.1 Articolo in rivista | 2000 | DE PLACIDO, Sabino; Lauria, Rossella; F., Perrone; Vernaglia, LOMBARDI ALESSANDRA; Carlomagno, Chiara; E., Varriale; Costanzo, Raffaele; L., Leo; DE LAURENTIIS, Michelino; Bianco, ANGELO RAFFAELE | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE | |
| Prognostic significance of multifocality in primary breast cancer. | 1.1 Articolo in rivista | 1994 | Morabito, A.; Perrone, F.; Lauria, R.; Carlomagno, Chiara; Marinelli, Alfredo; DE LAURENTIIS, Michelino; Martignetti, A.; Pettinato, Guido; Panico, L.; Petrella, G.; Gallo, C.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| IS THERE A STANDARD CHEMOTHERAPEUTIC REGIMEN FOR HORMONE-REFRACTORY PROSTATE CANCER? PRESENT AND FUTURE APPROACHES IN THE MANAGEMENT OF THE DISEASE. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | DI LORENZO, G; Autorino, R; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, R; Giordano, A; DE SIO, M; Darmiento, M; Bianco, Ar; DE PLACIDO, Sabino | |
| Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer. | 1.1 Articolo in rivista | 2012 | Giordano, A; Gao, H; Anfossi, S; Cohen, E; Mego, M; Lee, Bn; Tin, S; DE LAURENTIIS, Michelino; Parker, Ca; Alvarez, Rh; Valero, V; Ueno, Nt; DE PLACIDO, Sabino; Mani, Sa; Esteva, Fj; Cristofanilli, M; Reuben, Jm | |
| NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA | 1.1 Articolo in rivista | 2000 | Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. | 1.1 Articolo in rivista | 2009 | E., Montagna; G., Cancello; D., D'Agostino; Lauria, Rossella; Forestieri, Valeria; A., Esposito; L., Silvestro; Accurso, Antonello; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. | 1.1 Articolo in rivista | 2002 | Carlomagno, Chiara; Lauria, Rossella; DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, Erminia; Ferrara, Claudia; Milano, Andrea; Vernaglia, LOMBARDI ALESSANDRA; Costanzo, Raffaele; G., Catalano; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| A predictive index of axillary nodal involvement in operable breast cancer. | 1.1 Articolo in rivista | 1996 | DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE | |
| Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. | 1.1 Articolo in rivista | 1994 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
| The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE |